High-Purity Research Peptides with Free Shipping Within the U.S.
Cartalax
Cartalax
$75.00
Quantity
Description
Cartalax emerges as a promising peptide in musculoskeletal and connective tissue research. Acting on chondrocyte and extracellular matrix pathways under investigation, it supports optimal cartilage function, joint stability, and cellular resilience. By modulating structural protein synthesis and promoting adaptive repair, Cartalax contributes to improved systemic recovery and protection against stress‑induced damage in skeletal tissues.
Additional Information
Weight: 0.08 lbs
Dimensions: 0.87 × 1.18 × 0.87 in
Size: 5mg, 10mg
This product is intended solely for research purposes. It is not authorized for use in humans or animals and should only be handled by trained personnel in appropriate laboratory settings.
Highlights
Biochemical Profile
Stability :Stable lyophilized, refrigerated.
Solubility: Readily soluble in water and physiological saline
Storage Conditions: Store at 36‑46 °F (2‑8 °C)
Form: White to off‑white crystalline powder
Structural Properties
Amino acid sequence: Ala‑Glu‑Asp‑Gly
Molecular Mass: ~388.35 g/mol
Composition: C₁₄H₂₄N₄O₉
Architecture: Linear tetrapeptide (4 amino acids)
Biological Mechanism
Cartalax functions as a synthetic tetrapeptide (Ala‑Glu‑Asp‑Gly), engaging chondrocyte and extracellular matrix regulatory pathways to support cartilage resilience and optimize joint performance.
Key Mechanisms
Structural Reinforcement
Engages chondrocytes and extracellular matrix pathways, supporting cartilage integrity and joint stability.
Regenerative Adaptation
Stimulates connective tissue repair cascades that enhance resilience under mechanical and age‑related stress.
Inflammatory Modulation
Downregulates pro‑inflammatory signaling, promoting balanced recovery and reducing degenerative progression.
Metabolic Support
Optimizes nutrient and oxygen utilization in musculoskeletal tissues, reinforcing systemic repair and performance.
Metabolic Benefits
Energy Dynamics
Supports balanced mitochondrial activity in connective tissue cells, sustaining efficient ATP production under stress.
Nutrient Utilization
Enhances uptake and distribution of essential substrates in cartilage and musculoskeletal structures.
Oxygen Efficiency
Promotes improved oxygen delivery and utilization within joint and skeletal tissues, reinforcing resilience.
Adaptive Recovery
Stabilizes metabolic pathways that contribute to repair and regeneration during mechanical strain or age‑related decline.
Research Highlights
Cartalax demonstrates strong tolerability in investigative research settings, with only mild and short‑lived effects occasionally observed.
Structural Resilience
Experimental findings suggest Cartalax supports cartilage integrity and connective tissue stability, with potential relevance in age‑related musculoskeletal decline.
Regenerative Adaptation
Preclinical studies highlight stimulation of repair pathways in chondrocytes and extracellular matrix, contributing to enhanced tissue recovery.
Inflammatory Modulation
Research indicates downregulation of pro‑inflammatory markers and balanced signaling, supporting joint protection and systemic repair.
Joint Optimization
Investigations show improved nutrient and oxygen utilization in musculoskeletal tissues, reinforcing resilience and performance under mechanical strain.
Possible Research-Related Effects
Cartalax exhibits favorable tolerability in research contexts, with minor and short‑duration effects occasionally reported:
Favorable Tolerability
Cartalax demonstrates strong tolerability in investigative research settings, with only mild and short‑lived effects occasionally observed.
Transient Flushing
Brief localized sensations in joint or connective tissue regions, typically resolving without intervention.
Low-grade Fatigue
Mild tiredness noted in select studies, subsiding spontaneously.
Musculoskeletal Sensitivity
Occasional temporary shifts in joint comfort or flexibility during adaptive repair phases.
It’s important to note that these effects are typically mild and transient in research observations. However, comprehensive long-term safety data is still being collected.
Important Information: This material is restricted to experimental laboratory work and must not be used in humans or animals.
References
Cartalax Overview, Dosing & Safety. Peptide Database, 2024. — Editorial Team.
Cartalax Technical Specification Sheet. Peptide Biologix, 2024. — Research Monograph.
TARGET DOSSIER: Cartalax. Peptide Recon, 2025. — Peptide Reconnaissance Division.
Cartalax Peptide: Connective Tissue and Joint Research Pathways. Biolongevity Labs, 2025. — Editorial Team, reviewed by Ky H. Le.
Cartalax Peptide: Potential Roles in Regenerative Adaptation. Resident Resource Guide, 2024. — Resident Contributor.
Cartalax Peptide: Insights into Stress Response and Musculoskeletal Repair. Atlas of Science, 2023. — Editorial Team.
About Us
Zenergen Research Products is committed to supplying high-purity peptides intended for research use, with an emphasis on quality control and dependable delivery.
Contact Us
Copyright© 2026 Zenergen Research - All Rights Reserved.